Neogenomics Stock Gains as Rejuva Fresh® Launches EMSHAPE NEO PLUS® Study for Health and Aesthetics
- Rejuva Fresh® introduces EMSHAPE NEO PLUS® study, highlighting its benefits for aesthetics and health in female athletes.
- The treatment combines electromagnetic pulses and radio waves to build muscle, reduce fat, and stimulate collagen synthesis.
- Positive study results position EMSHAPE NEO PLUS® as a leading option for holistic wellness and aesthetic enhancement.
Rejuva Fresh® Advances Aesthetic and Health Treatments with EMSHAPE NEO PLUS® Study
Rejuva Fresh®, a prominent player in energy-based aesthetic technology, recently unveils a significant clinical study that showcases the capabilities of its EMSHAPE NEO PLUS® treatment. Conducted by Dr. Joseph Guinto at TRXN Chiropractic Care for Athletics and Injury Prevention in Orlando, Florida, the study emphasizes the device's dual role in enhancing aesthetics and improving health conditions. With a focus on female CrossFit athletes, the research investigates the treatment's efficacy in sculpting abs, firming skin, and toning buttocks while simultaneously addressing vital health issues such as weak pelvic floor control and irregular sleep patterns.
The EMSHAPE NEO PLUS® treatment protocol employs a unique blend of ultra-concentrated high-intensity electromagnetic pulses and high-frequency radio waves. This innovative approach not only promotes muscle building and fat reduction but also stimulates collagen synthesis, effectively combatting visible signs of aging. The clinical trial, which included ten participants in their early thirties, explored the device's potential in pelvic floor strengthening and functional core retraining. The positive outcomes from Dr. Guinto's study highlight EMSHAPE NEO PLUS® as a pioneering solution that merges aesthetic enhancement with health improvement, catering to individuals seeking a comprehensive approach to wellness.
Rejuva Fresh® expresses enthusiasm over the findings, which further establish EMSHAPE NEO PLUS® as a revolutionary option for those pursuing both aesthetic goals and health benefits. The device’s application in regenerative medicine not only redefines traditional aesthetic treatments but also positions it at the forefront of holistic health solutions. As demand grows for non-invasive procedures that deliver multiple benefits, Rejuva Fresh® is poised to lead the market with its innovative approach.
In related news, the findings of Dr. Guinto's study resonate with current trends in the wellness and aesthetic industries, where consumers increasingly seek treatments that address both appearance and health. The success of the EMSHAPE NEO PLUS® treatment protocol may influence future developments within the sector, as companies look to integrate similar comprehensive solutions.
As Rejuva Fresh® continues to explore the intersection of aesthetic technology and health improvement, it reinforces its commitment to enhancing the well-being of its clientele through groundbreaking treatments that prioritize both beauty and functional health.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

